Pulmonx
David Lemmon is an accomplished senior territory manager at Pulmonx Corporation, specializing in the sales and education of medical providers regarding the Zephyr Endobronchial Valve for emphysema patients. With extensive experience in sales and management roles across various companies, including owning and directing operations at EndoAmerica, LLC, and achieving top sales positions at Olympus Corporation of the Americas, David has demonstrated exceptional skills in building client relationships, executing marketing strategies, and leading teams to drive business growth. David's background also includes significant leadership experience in the US Army, where the development of team cohesion and efficiency was paramount. David holds a Bachelor of Science degree in Communications from Southern Illinois University, Carbondale.
This person is not in any teams
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1